{
    "2021-09-01": [
        [
            {
                "time": "",
                "original_text": "智飞生物：智飞绿竹新型病毒疫苗和工程疫苗产业化基地项目正式开工",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新型病毒疫苗",
                        "工程疫苗",
                        "产业化基地",
                        "开工"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医美行业",
                        "强化监管",
                        "安徽省",
                        "IVD集采",
                        "结果公布"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业：国内建议部分重点人群接种加强针",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国内",
                        "重点人群",
                        "接种",
                        "加强针"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "智飞生物",
                        "新冠疫苗",
                        "III期数据",
                        "变异株",
                        "有效"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122)：新冠疫苗拉动业绩快速增长 长期看好公司自研管线持续发力",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "业绩增长",
                        "自研管线",
                        "长期看好"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西部证券维持智飞生物买入评级，公司2021中报点评：自研产品业绩贡献显着，新冠疫苗有望加速放量",
                "features": {
                    "keywords": [
                        "西部证券",
                        "智飞生物",
                        "买入评级",
                        "2021中报",
                        "自研产品",
                        "业绩贡献",
                        "新冠疫苗",
                        "加速放量"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}